Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVR and IL-28B Expression in HCV Genotype 1 Treated with Pegasys and Copegus
NCT01447420Phase 4Completed
- Sponsor
- Roche
- Start
- Feb 2011
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of peginterferon alfa-2a, ribavirin in hepatitis C virus infection, sponsored by Roche. Started Feb 2011; status: completed.
02
Drugs
peginterferon alfa-2aribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT01447420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447420.